Rucaparib,Nivolumab
BMS,clovis oncology
['rucaparib', 'ovarian']
athena stage 3/4 ovarian cancer, maintenance mono rucaparib vs placebo hrd+ pfs; 28.7 vs 11.3 mos, hr:0.47 hrd- pfs; 12.1 vs 9.1 mos, hr:0.65 support for 1l maintenance parpi studies that change practice 
Consultant Med Oncologist at Cork Uni Hosp & UCC, cancer researcher, clinical trialist and mum of 3!